These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8243570

  • 1. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia.
    Wright L, Wilson SB, Milliken S, Biggs J, Kearney P.
    Exp Hematol; 1993 Dec; 21(13):1714-8. PubMed ID: 8243570
    [Abstract] [Full Text] [Related]

  • 2. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
    Mendoza-Maldonado R, Zentilin L, Fanin R, Giacca M.
    Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
    [Abstract] [Full Text] [Related]

  • 3. Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNA.
    Kearney P, Wright LA, Milliken S, Biggs JC.
    Exp Hematol; 1995 Aug; 23(9):986-9. PubMed ID: 7543419
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The effect of anti-bcr-abl hammerhead ribozyme on bone marrow purging].
    Wu Y, Chen YZ, Huang HF, Chen P, Lu LH.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):859-63. PubMed ID: 12958661
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Use of polymerase chain reaction for determining bcr/abl mRNA in human chronic myeloleukemia].
    Dominskiĭ DA, Pokrovskaia ES, Babushkina EA, Turkina AG, Grineva NI.
    Genetika; 1994 Dec; 30(12):1636-9. PubMed ID: 7534246
    [Abstract] [Full Text] [Related]

  • 13. Investigating and improving the specificity of ribozymes directed against the bcr-abl translocation.
    James H, Mills K, Gibson I.
    Leukemia; 1996 Jun; 10(6):1054-64. PubMed ID: 8667643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis.
    Martinelli G, Testoni N, Montefusco V, Amabile M, Saglio G, Ottaviani E, Terragna C, Bonifazzi F, de Vivo A, Pane F, Rosti G, Tura S.
    Haematologica; 1998 Jul; 83(7):593-601. PubMed ID: 9718863
    [Abstract] [Full Text] [Related]

  • 16. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R, Haas R, Sczakiel G.
    J Mol Biol; 1996 Jun 21; 259(4):632-44. PubMed ID: 8683570
    [Abstract] [Full Text] [Related]

  • 17. Ex vivo effects associated with the expression of a bcr-abl-specific ribozyme in a CML cell line.
    Wright LA, Milliken S, Biggs JC, Kearney P.
    Antisense Nucleic Acid Drug Dev; 1998 Feb 21; 8(1):15-23. PubMed ID: 9512092
    [Abstract] [Full Text] [Related]

  • 18. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
    Martinelli G, Terragna C, Amabile M, Montefusco V, Testoni N, Ottaviani E, de Vivo A, Mianulli A, Saglio G, Tura S.
    Haematologica; 2000 Jan 21; 85(1):40-6. PubMed ID: 10629590
    [Abstract] [Full Text] [Related]

  • 19. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
    Jazwiec B, Mahon FX, Pigneux A, Pigeonnier V, Reiffers J.
    Exp Hematol; 1995 Dec 21; 23(14):1509-14. PubMed ID: 8542939
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA.
    Lange W, Cantin EM, Finke J, Dölken G.
    Leukemia; 1993 Nov 21; 7(11):1786-94. PubMed ID: 8231247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.